Additionally, recent studies indicate that although incretin therapy is not yet routinely used in PCOS (especially in infertility treatment in PCOS), it may be considered in overweight or obese women with insulin resistance, especially when routine/standard methods fail [18]. This evidence concerns the gene GCG and Insulin resistance.